Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LUVERIS
- Pergoveris FD and Liquid China BE Study
- Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
- Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
- Effects of Recombinant LH in Patients With Repeated Implantation Failure
- Hormonal Mechanisms of Sleep Restriction - Axis Study
- Androgenic Profile Following Controlled Ovarian Stimulation
- Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism
- The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI
- Severe LH Suppressed Patients After Administration of a GnRH Antagonist
- A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
- Reproductive Hormonal Alterations in Obesity
- Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)
- A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Techno
- Lutropin Alfa in Women at Risk of Poor Response
- A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular
- A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
- A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
- A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age
- Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle
- To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
- The Luveris In Vitro Fertilization Trial
- Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
- Nordic Luveris Study
- Synchronization of Follicle Wave Emergence and Ovarian Stimulation
- Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
Clinical trials list
click for details